RheumMadness Podcast
The RheumMadness podcast is part of a rheumatology learning initiative sponsored by the Rheumatology Research Foundation Clinician Scholar Educator (CSE) Award. Go to https://sites.duke.edu/rheummadness/ to learn more. RheumMadness is created by David Leverenz, MD, who is the recipient of the CSE award. Dr. Leverenz has also received grant funding from Pfizer for quality improvement work unrelated to RheumMadness.
RheumMadness Podcast
5.9 B-Cell Breakaway Part 2
•
RheumMadness
•
Season 5
•
Episode 9
In this episode we are joined by some amazing collaborators from the EMEUNET to talk about the STRAP trials.
Links to the B-Cell Breakaway Scouting Reports:
- Obinutuzumab in lupus nephritis, by the University of Michigan Adult Rheumatology Fellowship Program
- CD-19 CAR T-cell therapy, by the Vanderbilt University Adult Rheumatology Fellowship Program
- STRAP trial, by the Emerging EULAR Network (EMEUNET)
Links to theMednet.org Q&As about this region:
- In the treatment of lupus nephritis, which patients may benefit from the use of rituximab or other B-cell depleting agents during induction?
- What are the potential barriers to the widespread use of obinutuzumab in proliferative lupus nephritis?
- How do you envision incorporating CAR-T therapy into your clinical practice?
- Does synovial biopsy provide diagnostic value in undifferentiated inflammatory arthritis?
To learn more about RheumMadness:
https://sites.duke.edu/rheummadness/
Subscribe to our newsletter:
https://lists.duke.edu/sympa/subscribe/rheummadness
Find us on social media:
Bluesky: @rheummadness.bsky.social
Instagram: https://www.instagram.com/rheummadness/
X: Follow #RheumMadness
Intro/outro music: Cheery Monday by Kevin MacLeod
Link: https://incompetech.filmmusic.io/song/3495-cheery-monday
License: http://creativecommons.org/licenses/by/4.0/